Distinct Longitudinal Changes in Immunoglobulin G N-Glycosylation Associate with Therapy Response in Chronic Inflammatory Diseases

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases

(2021) Silje Watterdal Syversen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Microbial butyrate synthesis indicates therapeutic efficacy of azathioprine in IBD patients

(2020) M Effenberger et al.   Journal of Crohns & Colitis

Dissecting Common and Unique Effects of Anti-α4β7 and Anti-Tumor Necrosis Factor Treatment in Ulcerative Colitis

(2020) Marisol Veny et al.   Journal of Crohns & Colitis

Glycosylation in health and disease

(2019) Colin Reily et al.   Nature Reviews Nephrology

Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients with Inflammatory Bowel Diseases

(2019) Konrad Aden et al.   GASTROENTEROLOGY

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

(2019) Nicholas A Kennedy et al.   Lancet Gastroenterology & Hepatology

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

(2019) Bruce E. Sands et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inflammatory bowel disease - glycomics perspective

(2019) Maja Hanić et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti–TNF-α Agents on B Lymphocytes: A Review of the Literature

(2018) Ozlem Pala et al.   CLINICAL THERAPEUTICS

Plasma N -Glycan Signatures Associate With Features of Inflammatory Bowel Diseases

(2018) Florent Clerc et al.   GASTROENTEROLOGY

Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases

(2018) Mirna Šimurina et al.   GASTROENTEROLOGY

Immunoglobulin G glycosylation in aging and diseases

(2018) Ivan Gudelj et al.   CELLULAR IMMUNOLOGY

Pharmacogenetics of treatments for inflammatory bowel disease

(2018) Marianna Lucafò et al.   Expert Opinion on Drug Metabolism & Toxicology

Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?

(2017) Michaela Seeling et al.   Nature Reviews Rheumatology

Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity

(2017) Benjamin Peschke et al.   Frontiers in Immunology

LaCyTools: A Targeted Liquid Chromatography–Mass Spectrometry Data Processing Package for Relative Quantitation of Glycopeptides

(2016) Bas C. Jansen et al.   JOURNAL OF PROTEOME RESEARCH

Role of aberrant IgG glycosylation in the pathogenesis of inflammatory bowel disease

(2016) Eiji Miyoshi et al.   Proteomics Clinical Applications

Combination of IgGN-glycomics and corresponding transcriptomics data to identify anti-TNF-α treatment responders in inflammatory diseases

(2015) Csaba Váradi et al.   ELECTROPHORESIS

Inflammatory Bowel Disease Associates with Proinflammatory Potential of the Immunoglobulin G Glycome

(2015) Irena Trbojević Akmačić et al.   INFLAMMATORY BOWEL DISEASES

Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: A critical review

(2015) Emanual Maverakis et al.   JOURNAL OF AUTOIMMUNITY

Association of Systemic Lupus Erythematosus With Decreased Immunosuppressive Potential of the IgG Glycome

(2015) Frano Vučković et al.   Arthritis & Rheumatology

Type I and type II Fc receptors regulate innate and adaptive immunity

(2014) Andrew Pincetic et al.   NATURE IMMUNOLOGY

Changes in IgG and total plasma protein glycomes in acute systemic inflammation

(2014) Mislav Novokmet et al.   Scientific Reports

IgG Subclasses and Allotypes: From Structure to Effector Functions

(2014) Gestur Vidarsson et al.   Frontiers in Immunology

Complex N-glycans: the story of the “yellow brick road”

(2013) Harry Schachter   GLYCOCONJUGATE JOURNAL

T cell–independent B cell activation induces immunosuppressive sialylated IgG antibodies

(2013) Constanze Hess et al.   JOURNAL OF CLINICAL INVESTIGATION

Glycosylation status of serum in inflammatory arthritis in response to anti-TNF treatment

(2013) E. S. Collins et al.   RHEUMATOLOGY

The role of Fc receptors and complement in autoimmunity

(2012) Sidonia Mihai et al.   AUTOIMMUNITY REVIEWS

mTNF reverse signalling induced by TNFα antagonists involves a GDF-1 dependent pathway: implications for Crohn's disease

(2012) Stefanie Derer et al.   GUT

Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1

(2012) Christian M Karsten et al.   NATURE MEDICINE

Alternative glycosylation modulates function of IgG and other proteins — Implications on evolution and disease

(2011) Olga Gornik et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations

(2011) Maja Pučić et al.   MOLECULAR & CELLULAR PROTEOMICS

Mannose-binding lectin does not explain the course and outcome of pregnancy in rheumatoid arthritis

(2011) Fleur E van de Geijn et al.   ARTHRITIS RESEARCH & THERAPY

Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding

(2010) Damian Houde et al.   MOLECULAR & CELLULAR PROTEOMICS

Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study

(2009) Fleur E van de Geijn et al.   ARTHRITIS RESEARCH & THERAPY

Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis

(2008) K Van Beneden et al.   ANNALS OF THE RHEUMATIC DISEASES

Initiation of the alternative pathway of murine complement by immune complexes is dependent onN-glycans in IgG antibodies

(2008) Nirmal K. Banda et al.   ARTHRITIS AND RHEUMATISM